Sanofi-Aventis S.A. ADR (SNY)

May 9, 2025, 8:35 PM EDT - 4 days ago

Hawaii in $700 million settlement with Bristol-Myers, Sanofi over Plavix warning label

BMY

May 9, 2025, 4:51 PM EDT - 4 days ago

Pharma Worries Shift to Prices From Trade. Trump's Next Plan Could Sink Stocks.

JNJ NVO NVS

May 8, 2025, 7:23 PM EDT - 5 days ago

Pressure is still on the pharma sector, says Mizuho's Jared Holz

ABBV AMGN BMY GILD JNJ LLY MRK

May 6, 2025, 7:08 AM EDT - 7 days ago

Sanofi: Investing in prevention builds Europe's health and competitiveness

Apr 30, 2025, 12:46 PM EDT - 13 days ago

Press Release: Annual General Meeting of April 30, 2025

Apr 30, 2025, 7:00 AM EDT - 13 days ago

Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader

Apr 29, 2025, 7:00 AM EDT - 14 days ago

Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race

Apr 24, 2025, 2:03 PM EDT - 19 days ago

Sanofi (SNY) Q1 2025 Earnings Call Transcript

Apr 24, 2025, 4:48 AM EDT - 19 days ago

Sanofi Sales, Profit Beat Expectations on Higher Demand for Skin, Asthma Drug

Apr 24, 2025, 1:33 AM EDT - 19 days ago

Sanofi's quarterly profit beats estimates on Dupixent boost, newer products

Apr 24, 2025, 1:30 AM EDT - 19 days ago

Press Release: Sanofi: strong Q1 performance and 2025 guidance confirmed

Apr 23, 2025, 2:44 AM EDT - 20 days ago

Novartis and Sanofi CEOs say EU should raise drug prices in face of tariffs

NVS

Apr 18, 2025, 11:31 AM EDT - 25 days ago

Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition

REGN

Apr 18, 2025, 11:15 AM EDT - 25 days ago

Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

REGN

Apr 15, 2025, 1:00 AM EDT - 4 weeks ago

Press Release: Sanofi's respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD

Apr 9, 2025, 9:50 AM EDT - 4 weeks ago

Global pharma shares plunge as Trump doubles down on tariff threat

ABBV AMGN AZN GSK LLY MRK NVS

Apr 8, 2025, 11:32 PM EDT - 5 weeks ago

Trump teases targeted tariffs on overseas drug manufacturers

AZN GSK IHE NVS PJP XPH

Apr 8, 2025, 1:11 PM EDT - 5 weeks ago

Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

Apr 3, 2025, 12:08 PM EDT - 5 weeks ago

Why Is French Pharma Giant Sanofi Stock Trading Higher On Thursday?

Apr 3, 2025, 1:00 AM EDT - 5 weeks ago

Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines

Apr 1, 2025, 12:11 PM EDT - 6 weeks ago

Bernstein's Courtney Breen: Merck, Novo Nordisk, others at high risk from tariffs

MRK NVO ABBV GSK

Mar 28, 2025, 4:07 PM EDT - 6 weeks ago

Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors

Mar 28, 2025, 2:27 PM EDT - 6 weeks ago

US FDA approves Sanofi's bleeding disorder therapy

Mar 28, 2025, 9:44 AM EDT - 6 weeks ago

AbbVie Vs. Sanofi: Which Is The Better Investment Right Now

ABBV

Mar 28, 2025, 2:00 AM EDT - 6 weeks ago

Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD

REGN

Mar 26, 2025, 2:00 AM EDT - 6 weeks ago

Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA

Mar 25, 2025, 2:00 AM EDT - 7 weeks ago

Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis

Mar 24, 2025, 2:30 AM EDT - 7 weeks ago

Press Release: Availability of the Q1 2025 Aide mémoire

Mar 20, 2025, 2:29 AM EDT - 7 weeks ago

Sanofi to acquire Dren Bio's immunology unit

Mar 20, 2025, 2:00 AM EDT - 7 weeks ago

Press Release: Sanofi to acquire Dren Bio's bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline

Mar 14, 2025, 2:18 PM EDT - 2 months ago

Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season

Mar 12, 2025, 10:12 AM EDT - 2 months ago

Sanofi Stock Forms Golden Cross As Dupixent Eyes FDA Green Light: Can The Bullish Run Continue?

Mar 11, 2025, 8:55 AM EDT - 2 months ago

Top 3 Health Care Stocks That May Keep You Up At Night In Q1

TSVT VRTX

Mar 8, 2025, 1:00 PM EST - 2 months ago

Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD

REGN

Mar 5, 2025, 12:10 PM EST - 2 months ago

Press release: Sanofi successfully prices EUR 1.5 billion of bond issue

Mar 4, 2025, 12:14 PM EST - 2 months ago

South African watchdog probes Novo Nordisk and Sanofi over insulin

NVO

Feb 26, 2025, 10:14 AM EST - 2 months ago

Health Rounds: Experimental Sanofi drug delays heart valve disease progression, and potentially surgery

Feb 26, 2025, 9:00 AM EST - 2 months ago

Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M

Feb 25, 2025, 1:00 AM EST - 2 months ago

Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma

Feb 22, 2025, 2:30 AM EST - 2 months ago

Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn's disease

Feb 19, 2025, 7:19 AM EST - 2 months ago

Sanofi: OpenAI's Research Agents Could Lead To Explosive Growth

Feb 19, 2025, 1:30 AM EST - 2 months ago

Press Release: Sanofi and CD&R sign Opella share purchase agreement

Feb 13, 2025, 2:09 PM EST - 3 months ago

Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d'Enregistrement Universel” containing the Annual Financial Report

Feb 13, 2025, 1:00 AM EST - 3 months ago

Press Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study

Feb 7, 2025, 1:13 AM EST - 3 months ago

Healthcare company Sanofi announces share buyback of up to 2 billion euros

Feb 7, 2025, 1:00 AM EST - 3 months ago

Press Release: Execution of a share buyback agreement for up to €2 billion

Feb 4, 2025, 5:30 AM EST - 3 months ago

MITEM PHARMA Continues Its Mission to Protect the Interests of Patients Suffering From Rare and Lethal Diseases by Acquiring the FLISINT® Speciality from SANOFI

Feb 3, 2025, 1:30 AM EST - 3 months ago

Agreement Between L'Oréal and Sanofi for the Repurchase by Sanofi of 2.3% of Its Own Shares Held by L'Oréal

Feb 3, 2025, 1:30 AM EST - 3 months ago

Press Release: Sanofi announces buy back of shares from L'Oréal

Jan 31, 2025, 1:00 AM EST - 3 months ago

Press Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant